P

Inventor

ROBERTS DAVID D

US38 patents
⚠️ This page may combine multiple inventors who share the name “ROBERTS DAVID D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

US HEALTH

20 patents
US6051549AApr 18, 2000

Heparin and sulfatide binding peptides from the type-I repeats of human thrombospondin and conjugates thereof

US HEALTH96 citations96
US5770563AJun 23, 1998

Heparin- and sulfatide binding peptides from the type I repeats of human thrombospondin and conjugates thereof

US HEALTH52 citations93
US5225330AJul 6, 1993

Diagnostic kit and diagnostic method utilizing carbohydrate receptors

US HEALTH25 citations92
US5217715AJun 8, 1993

Carbohydrate receptor for bacteria and method for use thereof

US HEALTH39 citations92
US5357041AOct 18, 1994

Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin

US HEALTH28 citations91
US5849701ADec 15, 1998

Peptide inhibitors of fibronectin and related collagen-binding proteins

US HEALTH29 citations89
US5491130AFeb 13, 1996

Peptide inhibitors of fibronectin and related collagen-binding proteins

US HEALTH39 citations89
US8344019B2Jan 1, 2013

Methods for the production of biliverdin

US HEALTH6 citations79
US7129052B1Oct 31, 2006

Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins

US HEALTH10 citations73
US5529904AJun 25, 1996

Diagnostic kit and diagnostic method for mycoplasma utilizing carbohydrate receptors

US HEALTH13 citations73
US10370439B2Aug 6, 2019

Prevention of tissue ischemia and related methods

US HEALTH1 citations72
US11285169B2Mar 29, 2022

Methods for modulating chemotherapeutic cytotoxicity

US HEALTH2 citations64
US11254735B2Feb 22, 2022

Prevention of tissue ischemia and related methods

US HEALTH0 citations62
US7745144B2Jun 29, 2010

Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins

US HEALTH1 citations62
US10407665B2Sep 10, 2019

Methods for generation of pluripotent and multipotent cells

US HEALTH1 citations59
US7504243B2Mar 17, 2009

Methods for the production of biliverdin

US HEALTH4 citations58
US11053314B2Jul 6, 2021

Methods to eliminate cancer stem cells by targeting CD47

US HEALTH1 citations57
US6875855B1Apr 5, 2005

Nucleic acid and amino acid sequences of hemoglobin-response genes in candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated candida albicans infection

US HEALTH3 citations57
US7332167B2Feb 19, 2008

Nucleic acid and amino acid sequences of hemoglobin-response genes in Candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated Candida albicans infection

US HEALTH0 citations46
US7618789B2Nov 17, 2009

Use of semenogelin in the diagnosis, prognosis and treatment of cancer

US HEALTH0 citations45

ISENBERG JEFFREY S

4 patents

READ RITE CORP

3 patents

CENSTOR CORP

3 patents

UAB RESEARCH FOUNDATION

2 patents

US ARMY

2 patents

SEAGATE TECHNOLOGY LLC

1 patent

KRIVAN HOWARD C

1 patent

THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES

1 patent

ROBERTS DAVID D

1 patent